CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 4 Planned sale Director sold 10,000 shares at $50.07 ($500,747)
- 4 Planned sale Director sold 4,500 shares at $50.00 ($225,000)
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Planned sale Director sold 3,250 shares at $43.49 ($141,343)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
Page 3 of 65 · 1,286 filings